You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

Article metrics

Article menu

Download PDFPDF

Clinical/translational cancer immunotherapy
Original research
Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2021 to March 2026

AbstractFullPdf
Nov 2021627629191
Dec 202128929057
Jan 202210110542
Feb 2022747837
Mar 202210010234
Apr 2022747528
May 202212012028
Jun 202216016334
Jul 202211811933
Aug 202211511530
Sep 202212612729
Oct 202211811933
Nov 2022979736
Dec 2022868617
Jan 2023747723
Feb 202311711722
Mar 2023808114
Apr 2023494910
May 202361619
Jun 2023565615
Jul 2023585824
Aug 2023707017
Sep 2023555512
Oct 2023555516
Nov 2023616114
Dec 2023565620
Jan 2024404115
Feb 2024575737
Mar 2024909140
Apr 2024616126
May 2024525211
Jun 2024555528
Jul 20247475168
Aug 20244443150
Sep 20244343509
Oct 2024454522
Nov 2024484921
Dec 2024616226
Jan 2025717331
Feb 2025717230
Mar 2025606026
Apr 202512112130
May 2025777836
Jun 2025535331
Jul 2025110
Sep 2025110
Feb 2026110
Mar 2026110
Total412441562062